Esperion Therapeutics (ESPR) Tumbles on Price Cuts

Esperion Therapeutics Inc (NASDAQ: ESPR) shares fell 35% to $22.80 following an update on ETC-1002 global Phase 3 strategy and analyst price target cuts. Share volume was 848,000, compared to an all-day average of 310,000